Professional Documents
Culture Documents
Orlistat (Xenical)
Junnosuke Kato
January 25, 2011
The Print Ad
Basic Needs:
Reduction of excess body
fat also decreases the
chances of a person to
develop certain types of
illnesses
3. Who competes w/ Xenical?
Lesofat
Main competitor after expiry
of patent
Smuggled generic
formulations
Counterfeit products
Other anti-obesity agents
(Sibutramine HCl)
3. How does its competitors fair?
PRICE/QUALITY LOW-END MID-RANGE PREMIUM
MATRIX QUALITY QUALITY QUALITY
HIGH PRICE
Salbutramine HCl
Xenical
LOW PRICE
Lesofat
Generics
Counterfeit
4. Where is the gap?
Xenical patented Orlistat
Greatest exposure time to clients among its
competitors
A certain level of quality & trust is perceived to the
original producer
5. What is the size of its market?
No information was extracted from the print ad
Given the sheer number of distributors (e.g.
Mercury Drug Store), a relatively huge market
size primarily from over-the-counter clients is
expected
6. What is the product?
Anti-obesity agent
Taken once a day during meals
Prevents the absorption of fat from diet
Reduces caloric intake
Moderately lowers blood pressure
Moderately decreases risk of diabetes
7. How much is it?
Not in the print ad
1 capsule (120 mg) costs P41 (MIMS)
8. Adopting the across-the-line
promotion
Internet-based marketing
Social network
Other media
Magazine and newspaper print ads
TV commercials
Billboard posters
Text contact
9. Where to buy?
All major drug stores in the country
10. The generic winning strategy
Indicate more studies to back up claims
Maintain marketing the aesthetic benefits of the
product
Bank on the fact that Xenical was the patent
holder of Orlistat
The Print Ad